Prenatal Administration of Betamethasone and Neonatal Respiratory Distress Syndrome in Multifetal Pregnancies: A Randomized Controlled Trial

Abbasalizadeh F., Pouya K., Zakeri R., Asgari-Arbat R., Abbasalizadeh S., Parnianfard N.

CURRENT CLINICAL PHARMACOLOGY, cilt.15, sa.2, ss.164-169, 2020 (ESCI, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.2174/1574884714666191007154936
  • Dergi Adı: CURRENT CLINICAL PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Agricultural & Environmental Science Database, Biotechnology Research Abstracts, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.164-169
  • Anahtar Kelimeler: Neonatal respiratory distress syndrome, multifetal pregnancies, betamethasone, antenatal corticosteroid, clinical trial, gestation, INFANTS, CORTICOSTEROIDS, GESTATION, SINGLETON, OUTCOMES
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: Neonatal Respiratory Distress Syndrome (NRDS) is one of the most frequent causes of neonatal mortality especially in premature infants. Although it has been well established that maternal antenatal corticosteroid therapy has a positive effect on NRDS reduction, yet the effectiveness of this treatment in multifetal pregnancies is dubious.